about
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that...
Read More213.2K XNAS Volume
XNAS 04 Jun, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Upstream Bio Inc. is on 10 Jun 2025 for the purpose of Upstream Bio Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Upstream Bio Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..